Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Donors for SARS-CoV-2 Convalescent Plasma for a Controlled Clinical Trial: Donor Characteristics, Content and Time Course of SARS-CoV-2 Neutralizing Antibodies ; volume:48 ; number:3 ; year:2021 ; pages:137-147 ; extent:11
Transfusion medicine and hemotherapy ; 48, Heft 3 (2021), 137-147 (gesamt 11)
- Urheber
-
Körper, Sixten
Jahrsdörfer, Bernd
Corman, Victor M.
Pilch, Jan
Wuchter, Patrick
Blasczyk, Rainer
Müller, Rebecca
Tonn, Torsten
Bakchoul, Tamam
Schäfer, Richard
Juhl, David
Schwarz, Tatjana
Gödecke, Nina
Burkhardt, Thomas
Schmidt, Michael
Appl, Thomas
Eichler, Hermann
Klüter, Harald
Drosten, Christian
Seifried, Erhard
Schrezenmeier, Hubert
- DOI
-
10.1159/000515610
- URN
-
urn:nbn:de:101:1-2021061000140203724892
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Körper, Sixten
- Jahrsdörfer, Bernd
- Corman, Victor M.
- Pilch, Jan
- Wuchter, Patrick
- Blasczyk, Rainer
- Müller, Rebecca
- Tonn, Torsten
- Bakchoul, Tamam
- Schäfer, Richard
- Juhl, David
- Schwarz, Tatjana
- Gödecke, Nina
- Burkhardt, Thomas
- Schmidt, Michael
- Appl, Thomas
- Eichler, Hermann
- Klüter, Harald
- Drosten, Christian
- Seifried, Erhard
- Schrezenmeier, Hubert
Ähnliche Objekte (12)
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2
Converting non-neutralizing SARS-CoV-2 antibodies into broad-spectrum inhibitors
Neutralizing and enhancing antibodies against SARS-CoV-2
Neutralizing antibody titres in SARS-CoV-2 infections
Peptide variants of a SARS-CoV-2 neutralizing protein
Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
SARS-CoV-2-Arbeitsschutzstandard
Data mining of coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV
Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
Quantitation of SARS-CoV-2 neutralizing antibodies using virus-like particles
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
Broadly neutralizing human antibodies against Omicron subvariants of SARS-CoV-2